Advertisement
Organisation › Details
Albumedix Ltd.
Albumedix is a science-driven, life-science company focused on enabling the creation of superior biopharmaceuticals utilizing our recombinant human albumin products. We believe in empowering excellence to enable advanced therapies and facilitate otherwise unstable drug candidates reach patients worldwide. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical and medical device companies worldwide. Headquartered in Nottingham, England with more than 100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago. *
Start | 1984-01-01 established | |
Group | Sartorius (Group) | |
Industry | Recombumin® | |
Street | 59 Castle Boulevard Castle Court | |
City | NG7 1FD Nottingham | |
Tel | +44-115-9553379 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | C: 51 to 100 (2022-08-08) |
Currency | GBP | |
Annual sales | 33,000,000 (revenue, expected (2022) 2022-12-31) | |
* Document for »About Section«: Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer". | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Sartorius (Group)
- [1] Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen....
- [2] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....
- [3] Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen....
- [4] Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg....
- [5] Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen....
- [6] Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen....
- [7] Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen....
- [8] Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne....
- [9] Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen...
- [10] mk2 Biotechnologies GmbH. (6/28/22). "Press Release: mk2 Biotechnologies and Sartorius Stedim Biotech Join Forces to Develop a Biologics Production Platform"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top